Panagora Asset Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-417,064
| Closed | -$6.56M | – | 1308 |
|
|
2024
Q1 | $6.56M | Buy |
417,064
+181,219
| +77% | +$2.79M | 0.03% | 295 |
|
|
2023
Q4 | $3.8M | Buy |
235,845
+144,097
| +157% | +$1.84M | 0.02% | 385 |
|
|
2023
Q3 | $1.17M | Buy |
+91,748
| New | +$1.27M | 0.01% | 726 |
|
|
2023
Q1 | – | Sell |
-41,304
| Closed | -$677K | – | 1560 |
|
|
2022
Q4 | $677K | Buy |
41,304
+267
| +0.7% | +$4.34K | ﹤0.01% | 1040 |
|
|
2022
Q3 | $759K | Sell |
41,037
-67,184
| -62% | -$1.05M | 0.01% | 972 |
|
|
2022
Q2 | $1.42M | Sell |
108,221
-13,921
| -11% | -$154K | 0.01% | 745 |
|
|
2022
Q1 | $1.13M | Buy |
122,142
+39,816
| +48% | +$339K | 0.01% | 880 |
|
|
2021
Q4 | $804K | Buy |
82,326
+60,760
| +282% | +$1.14M | ﹤0.01% | 1021 |
|
|
2021
Q3 | $733K | Buy |
21,566
+7,993
| +59% | +$255K | ﹤0.01% | 1119 |
|
|
2021
Q2 | $497K | Buy |
13,573
+10,510
| +343% | +$407K | ﹤0.01% | 1320 |
|
|
2021
Q1 | $137K | Sell |
3,063
-5,437
| -64% | -$253K | ﹤0.01% | 1833 |
|
|
2020
Q4 | $485K | Hold |
8,500
| – | – | ﹤0.01% | 1241 |
|
|
2020
Q3 | $436K | Sell |
8,500
-23,031
| -73% | -$1.13M | ﹤0.01% | 1218 |
|
|
2020
Q2 | $1.88M | Hold |
31,531
| – | – | 0.01% | 696 |
|
|
2020
Q1 | $1.3M | Buy |
+31,531
| New | +$1.75M | 0.01% | 738 |
|
Other funds holding DCPH
Panagora Asset Management's DCPH Position: Q2 2024 in Review
Panagora Asset Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 417,064 shares — an estimated $6.56M sold.
Panagora Asset Management first reported a position in DCPH in Q1 2020 and held it in 15 quarters. The position peaked at $6.56M in Q1 2024. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Panagora Asset Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Panagora Asset Management sold 417,064 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $6.56M.
- Panagora Asset Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 15 quarters.
- Panagora Asset Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $6.56M in Q1 2024.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Panagora Asset Management's 13F filing for Q2 2024, filed 29 Jul 2024.